Avid Bioservices, Inc.
CDMODrugs in Pipeline
8
Phase 3 Programs
5
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
Flortaucipir F18
Alzheimer Disease
florbetapir (18F)
Alzheimer's Disease
18F-AV-133
Parkinson's Disease
flortaucipir F 18
Alzheimer Disease
Florbetapir F 18
Alzheimer Disease
[11C]-PIB
Alzheimer's Disease
18F-AV-45
Dementia With Lewy Bodies
florbetapir 18F
Alzheimer's Disease
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Flortaucipir F18 | Phase 3 | Alzheimer Disease | - | - |
florbetapir (18F) | Phase 3 | Alzheimer's Disease | - | - |
18F-AV-133 | Phase 3 | Parkinson's Disease | - | - |
flortaucipir F 18 | Phase 3 | Alzheimer Disease | - | - |
Florbetapir F 18 | Phase 3 | Alzheimer Disease | - | - |
[11C]-PIB | Phase 2 | Alzheimer's Disease | - | - |
18F-AV-45 | Phase 2 | Dementia With Lewy Bodies | - | - |
florbetapir 18F | Phase 2 | Alzheimer's Disease | - | - |
Frequently asked questions
What is in Avid Bioservices, Inc.'s drug pipeline?→
CatalystAlert tracks 8 drug candidates in Avid Bioservices, Inc.'s (CDMO) pipeline across Phase 3, Phase 2. Its lead program is Flortaucipir F18 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Avid Bioservices, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Avid Bioservices, Inc. (CDMO) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track CDMO biotech catalysts?→
Add CDMO to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Avid Bioservices, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.